WELSPUN INDIA LTD. - 514162 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation to Schedule Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 Welspun India Ltd - 514162 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Further to our intimation dated September 16, 2021 we wish to inform that the Investor Day of Welspun India Limited originally scheduled to be convened on Thursday, September 23, 2021 is being rescheduled to Thursday, October 28, 2021. Welspun India Ltd - 514162 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Disclosure of information pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Welspun India to boost capacity to meet overseas demand
Will increase towel manufacturing capacity at its Anjar plant Welspun India Ltd - 514162 - Capacity Enhancement
Board at its meeting held on. September 18, 2021 has approved plan to augment towel manufacturing capacity by ~20% i.e., 16,600MTPA at Anjar from 85,400 MTPA to 102,000MTPA. Further, Board of the wholly owned subsidiary viz. Welspun Flooring Limited, at its meeting held today i.e. September 18, 2021, has approved capex of ~ Rs. 1,436 mn to be invested over FY22 and FY23. Welspun India Ltd - 514162 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company informs the stock exchange about details of Investor Day Invite to be held on Thursday, September 23, 2021 at 3:30 PM Indian Standard Time.
Welspun becomes 1st Indian firm to get US FDA approval for 3 ply surgical masks
The BIS and CE certified product from Welspun India has now got all the required certifications to supply to global markets, including for critical medical uses, the company statement said. Welspun India looks at 730 crore turnover from e-commerce
Expects 12,500 crore total turnover by FY25
Welspun India share price rises nearly 10% on USFDA approval for its 3-ply surgical mask
The share touched a 52-week high of Rs 145.45 and a 52-week low of Rs 51.15 on 29 July, 2021 and 02 September, 2020, respectively. WELSPUN INDIA LTD. - 514162 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Welspun India Limited has become the first Indian Company to receive US FDA 510(k) approval for its 3 Ply Surgical Masks.